Is Archer Aviation Stock a Buy?

Archer Aviation recently acquired approximately 300 patents from the insolvent Lilium for $21 million, expanding its intellectual property portfolio to over 1,000 assets and strengthening its competitive moat in the eVTOL market. The company, holding over $1.7 billion in cash, is actively building aircraft and establishing its first commercial network in the UAE, while also pursuing a significant defense contract that could accelerate its path to profitability. Despite a recent 32% stock surge and an $8.4 billion market cap, shares trade at roughly 100 times projected 2026 sales, reflecting a speculative valuation dependent on rapid revenue growth post-2027 and successful FAA certification amidst competitive pressures.

Analysis

Archer Aviation (ACHR) has strategically expanded its intellectual property by acquiring approximately 300 patents from the insolvent Lilium for $21 million, increasing its patent portfolio to over 1,000 assets. This move strengthens Archer's competitive moat within the consolidating eVTOL sector, where many rivals have struggled post-SPAC boom. The company is actively building six Midnight aircraft and establishing its first commercial network in the UAE, which could provide earlier operational validation compared to the U.S. regulatory timeline.

Archer maintains a robust financial position with over $1.7 billion in cash as of its Q2 2025 report, providing capital for certification and initial production. A significant defense opportunity, including a partnership with Anduril and existing U.S. Air Force testing, could provide substantial revenue faster than commercial operations, potentially altering the investment thesis. The company raised $300 million in 2025 specifically to fund defense work and manufacturing growth.

Despite a 32% stock surge since October, Archer's shares trade at a high valuation of approximately 100 times projected 2026 sales, reflecting an $8.4 billion market cap. This premium valuation is contingent on ultra-fast revenue growth from 2027 to 2030 and successful FAA type and production certification, which remains incomplete. Delays in regulatory approval or manufacturing could necessitate further shareholder dilution and expose the company to competitive pressures from rivals like Joby Aviation.

Key Decisions for Investors

• Investors should closely monitor Archer's progress on FAA type and production certification, as well as the outcome of potential defense contract awards, which are critical catalysts for de-risking the high valuation.
• Given the speculative nature and high valuation (100x 2026 sales), investors should assess their risk tolerance for a company reliant on significant future execution and potential shareholder dilution if delays occur.
• Evaluate competitive developments, particularly how rivals like Joby Aviation progress with their own certifications and commercialization efforts, as this could impact Archer's market share and growth trajectory.